Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

View:
Post by fuzzyjr on Dec 14, 2022 5:56pm

Sh police

Removed my post for saying "while our investment takes a S h l t kicking"
I couldn't reply to the pm so here is again - what's the problem Sh?  I'll review the policy, frick me!
Comment by JDavenport on Dec 14, 2022 6:24pm
Are you getting notifications from Stockhouse when they delete posts? Email, maybe? jd
Comment by beenthere on Dec 14, 2022 8:13pm
Post removed. SH gives the reasons. Looks like they have got smart enough that regardless how you try to hide it they what the word you wanted to post. For me I couldn't care less! With BTI done I'm done! Fu StockHouse!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities